"The patent application you refer to was withdrawn by Nyrada, not rejected. It covered early compounds that are no longer of value. Compounds that were developed subsequent to thatpatent application are far more potent. These are novel compounds that will provide composition of matter protection covering TBI and stroke indications." Be clear about what you allege. DYOR
NYR Price at posting:
23.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)